CLINICAL_TRIALS
research
· 2026-02-06
Clinical Trial Update: Anthocyanin-Rich Table Grape Powder for Prophylaxis of Post-Operative Atrial Fibrillation [Phase 1, Phase 2]
Summary
A Phase 1/2 clinical trial is evaluating anthocyanin-rich table grape powder to prevent postoperative atrial fibrillation and is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Michigan | Conditions: Post-operative Atrial Fibrillation (POAF) | Phase 1, Phase 2 | Status: RECRUITING